Rheumatology Patient Registry and Biorepository
-
- STATUS
- Recruiting
-
- End date
- Jun 1, 2040
-
- participants needed
- 5000
-
- sponsor
- Yale University
Summary
To facilitate clinical, basic science, and translational research projects involving the study of rheumatic diseases.
Description
A rheumatology biorepository will be created to permit comparative analyses between the rheumatic diseases in order to increase the understanding of disease pathogenesis. Patients diagnosed with rheumatic diseases are invited to participate in this study. These rheumatic diseases include, but are not limited to: adult onset Still's disease, ankylosing spondylitis, psoriatic arthritis, reactive arthritis, antiphospholipid syndrome, systemic lupus erythematosus, Behcet's disease, dermatomyositis, polymyositis, giant cell arteritis and other vasculitides, Lyme's disease, mixed connective tissue disease, polymyalgia rheumatica, rheumatoid arthritis, sarcoidosis, systemic sclerosis (scleroderma), Sjogren's syndrome, and undifferentiated connective tissue disease. Healthy volunteers are also invited to participate in this study.
Details
| Condition | Dermatomyositis, Rheumatism, Ankylosing spondylitis, Ankylosing spondylitis, Psoriasis, Antiphospholipid Syndrome, Antiphospholipid Syndrome, Behcet's Syndrome, Adult Onset Still's Disease, CONNECTIVE TISSUE DISEASE, dermatomyositis (connective tissue disease), Sicca Syndrome, Reiter's syndrome, Reiter's syndrome, PSORIATIC ARTHRITIS, PSORIATIC ARTHRITIS, Lyme Disease, Lyme Disease, Giant Cell Arteritis, Rheumatoid Arthritis, Rheumatoid Arthritis, Scleroderma, Systemic sclerosis, Scleroderma, Anterior uveitis, Anterior uveitis, Polymyalgia Rheumatica, Myositis, Myositis, Dermatosis, SYSTEMIC LUPUS ERYTHEMATOSUS, SYSTEMIC LUPUS ERYTHEMATOSUS, Lyme Disease Vaccine, Musculoskeletal Disease, Lymphoproliferative Disorder, Mixed Connective Tissue Disease, Sarcoidosis, Sarcoidosis, Arthritis, Polymyositis, dermatomyositis (connective tissue disease) |
|---|---|
| Age | 18-99 years |
| Clinical Study Identifier | NCT04402086 |
| Sponsor | Yale University |
| Last Modified on | 19 February 2024 |
How to participate?
,
You have contacted , on
Your message has been sent to the study team at ,
What happens next?
- You can expect the study team to contact you via email or phone in the next few days.
- Sign up as volunteer to help accelerate the development of new treatments and to get notified about similar trials.
You are contacting
Primary Contact
Additional screening procedures may be conducted by the study team before you can be confirmed eligible to participate.
Learn moreIf you are confirmed eligible after full screening, you will be required to understand and sign the informed consent if you decide to enroll in the study. Once enrolled you may be asked to make scheduled visits over a period of time.
Learn moreComplete your scheduled study participation activities and then you are done. You may receive summary of study results if provided by the sponsor.
Learn moreSimilar trials to consider
Browse trials for
Not finding what you're looking for?
Sign up as a volunteer to stay informed
Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.
Sign up as volunteer
Lorem ipsum dolor sit amet consectetur, adipisicing elit. Ipsa vel nobis alias. Quae eveniet velit voluptate quo doloribus maxime et dicta in sequi, corporis quod. Ea, dolor eius? Dolore, vel!
No annotations made yet
Add a private note
- Select a piece of text from the left.
- Add notes visible only to you.
- Send it to people through a passcode protected link.
Study Definition
WikipediaAdd a private note
- Select a piece of text.
- Add notes visible only to you.
- Send it to people through a passcode protected link.